| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00034 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 5.5e-05 | 1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -3.9e-05 | 1 |